The U.S. Securities and Exchange Commission is stepping up its scrutiny of leveraged exchange-traded products as violent market swings have prompted a spate of complaints.
The surge in volatility amid the coronavirus pandemic has sparked a reckoning of sorts for leveraged products, which use derivatives to boost returns of the securities they track. While those contracts can boost gains, they tend to amplify losses as well. A total of 16 leveraged offerings
“It’s pretty obvious that there’s sort of a widespread lack of understanding ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.